<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02966912</url>
  </required_header>
  <id_info>
    <org_study_id>442702</org_study_id>
    <nct_id>NCT02966912</nct_id>
  </id_info>
  <brief_title>Magnesium Supplementation for Primary Prevention of Heart Failure in Obesity</brief_title>
  <official_title>Magnesium Supplementation for Primary Prevention of Heart Failure in Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Providence VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Providence VA Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to investigate whether nutritional supplementation with
      magnesium can improve cardiovascular structure and function in participants with obesity -
      with a long-term goal of preventing clinical heart failure. Specifically, in a randomized
      open-label pilot study, we will assess whether dietary Magnesium (Mg) supplementation (versus
      no supplementation) for 24 weeks in obese patients will improve left ventricular (LV) mass.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators propose a 24-week therapeutic trial involving 40 participants with obesity
      from the Providence VA Medical Center without clinical heart failure. 20 participants will be
      treated with 400 mg of Magnesium Oxide twice daily, while 20 participants will receive no
      treatment. The trial tests the hypothesis that oral Mg supplementation will improve: LV
      structure (by LV mass, steatosis, and ECV), LV function (systolic and diastolic), vascular
      health (systolic blood pressure and aortic pulse wave velocity) and visceral adiposity.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular mass (by cardiac MRI)</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Left ventricular myocardial triglyceride content (by cardiac MRI)</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Left ventricular extracellular volume fraction (by cardiac MRI)</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systolic blood pressure</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic pulse wave velocity (by cardiac MRI)</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Magnesium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 participants will be treated with 400 mg of Magnesium Oxide twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 participants will receive no treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>400 mg of Magnesium Oxide twice daily for 24 weeks</intervention_name>
    <arm_group_label>Magnesium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Open label (none)</intervention_name>
    <arm_group_label>Comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Body mass index greater than 30 kg/m2

        Exclusion Criteria:

          1. History of hospitalization for heart failure (systolic or diastolic);

          2. Unstable angina or prior myocardial infarction;

          3. LV ejection fraction &lt;50% on imaging study;

          4. Valvular heart disease (stenosis or insufficiency) greater than moderate degree;

          5. Renal dysfunction, serum creatinine &gt;2.5 mg/dL or estimated creatinine clearance &lt;30
             mL/min/1.73 m2 (30),

          6. Pregnant women or actively breastfeeding women

          7. History of drug supplementation within the last 6 months in which more than 50
             miliequivalents per day of supplemental magnesium is contained
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Siddique A Abbasi, MD</last_name>
    <phone>4012737100</phone>
    <phone_ext>2265</phone_ext>
    <email>siddique_abbasi@brown.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Providence VA Medical Center</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Siddique A Abbasi, MD</last_name>
      <phone>401-273-7100</phone>
      <phone_ext>2265</phone_ext>
      <email>siddique_abbasi@brown.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 15, 2016</study_first_submitted>
  <study_first_submitted_qc>November 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2016</study_first_posted>
  <last_update_submitted>November 15, 2016</last_update_submitted>
  <last_update_submitted_qc>November 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Providence VA Medical Center</investigator_affiliation>
    <investigator_full_name>Siddique Abbasi</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

